InvestorsHub Logo
Followers 62
Posts 7515
Boards Moderated 1
Alias Born 01/02/2003

Re: MA52TA post# 420903

Saturday, 01/27/2024 8:47:48 AM

Saturday, January 27, 2024 8:47:48 AM

Post# of 424507
MA5...IMO such important news is best delivered with a link, for a better understanding of the full details....i.e....if the Brave study did not show statistical significance, was there any positive trend that demonstrated that Vascepa ameliorated Alzheimers...or delayed the onset of Alzheimer's symptoms... as shown by the cognitive testing results or by the biomarker results in the study.

If so, the safety of Vascepa, combined with the severity of Alzheimers disease, might lead to the approval of Vascepa as treatment of AZ...perhaps contingent on the initiation of a larger study.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News